Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid
NCT03846973
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class
Conditions
Tranexamic Acid
Interventions
DRUG:
Tranexamic Acid
OTHER:
Placebo
Sponsor
Hamad Medical Corporation